Dogan Fidan

Estimated annual numbers of US acute‐care hospital patients at risk for venous thromboembolism

Frederick A. Anderson, Maxim Zayaruzny, John A. Heit et al. · American Journal of Hematology · 2007 · 288 citations · Full text

Medicine, Internal Medicine, Cost-effectiveness Analysis +16

Life-Years Gained From Modern Cardiological Treatments and Population Risk Factor Changes in England and Wales, 1981–2000

Belgin Ünal, Julia Critchley, Dogan Fidan et al. · American Journal of Public Health · 2005 · 99 citations · Full text

Public Health, Cardiology, Nutrition +17

Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study

Alec Miners, Martina Garau, Dogan Fidan et al. · BMJ · 2004 · 90 citations · Full text

Pharmacy, Health Administration, Comparative Effectiveness Research +15

Antibiotic research and development: business as usual?

Stephan Harbarth, Ursula Theuretzbacher, Judith Hackett et al. · Journal of Antimicrobial Chemotherapy · 2015 · 83 citations · Full text

Pharmacy, Pharmacoeconomics, Antimicrobial Resistance +12

Cost-effectiveness of clopidogrel treatment in percutaneous coronary intervention: a European model based on a meta-analysis of the PCI-CURE, CREDO and PCI-CLARITY trials

Jenny Berg, Dogan Fidan, Peter Lindgren · Current Medical Research and Opinion · 2008 · 22 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17